Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Chemical Biology & Drug Design|April 10, 2015
Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15Xin Wang, Pádraig D'Arcy, Thomas R Caulfield, et al.
Plos One|April 9, 2015
Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implicationsAneel Paulus, Kasyapa S Chitta, Paul K Wallace, et al.
Southern Medical Journal|December 1, 2022
Impact of Benzodiazepine Use on Length of Stay and 30-Day ED Visits among Hospitalized Hematopoietic Stem Cell Transplant RecipientsShehzad K Niazi, Madiha Iqbal, Aaron C Spaulding, et al.
The Journal of Supportive Oncology|January 7, 2012
Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patientsAbhisek Swaika, Aneel Paulus, Kena C Miller, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 29, 2019
Survival trends in glioblastoma and association with treating facility volumeSonikpreet Aulakh, Michelle R DeDeo, Joseph Free, et al.
Hematological Oncology|April 30, 2022
Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial resultsSikander Ailawadhi, Ricardo D Parrondo, Muhamad Alhaj Moustafa, et al.
Cancers|November 27, 2021
Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age ReportingThejus Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, et al.
Cancer Medicine|August 17, 2023
The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancersSikander Ailawadhi, Meghna Ailawadhi, Navnita Dutta, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 24, 2021
Trends in Early Mortality From Multiple Myeloma: A Population-Based AnalysisVivek Kumar, Meghna Ailawadhi, Navnita Dutta, et al.
British Journal of Haematology|December 17, 2011
Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent mannerAisha Masood, Kasyapa Chitta, Aneel Paulus, et al.
Pageof 5